“…Abbreviations: IRS, insulin receptor substrate proteins; GRB2, growthfactor-receptor-bound protein-2; mSOS, mammalian son of sevenless nucleotide exchange factor; Ras, small G protein of Ras family; c-Raf, cytoplasmic serine/threonine-specific protein kinase Raf; MEK, mitogene-activated protein kinase; ERK1/2, extracellular signalregulated kinases 1 and 2; p85/p110 PI 3K, heterodimeric p85/p110 phosphatidylinositol 3-kinase; PTEN, phosphatase and tensin homologue; PDK1, phosphoinositide-dependent kinase 1; PKC, protein kinase C; AKT, protein kinase B; mTOR, mammalian target of rapamycin; GSK3, glycogen synthase kinase 3; FoxO1, forkhead box O1 protein; JAK2, Janus kinase-2; STAT3, signal transducer and activator of transcription of the type 3; PIP 2 and PIP 3 , phosphatidylinositol 3,4-diphosphate and phosphatidylinositol 3,4,5-triphosphate, respectively differentiation and the other processes in neuronal cells. The activation of PI 3-kinase leads to phosphorylation and activation of AKT kinase that regulates the metabolism and cell survival via numerous downstream proteins in the peripheral insulin-sensitive tissues as well as in the CNS, primarily in hypothalamic neurons (Iskandar et al, 2010). AKT kinase partly facilitates signal transduction via phosphorylation and cytoplasmic sequestering of forkhead-box protein O1, a negative regulator of insulin signaling, whose nuclear translocation is associated with obesity and hyperphagia (Kitamura et al, 2006).…”